3-Hydroxyphenazepam Stats & Data
Brc1ccc2NC(=O)C(O)N=C(c3ccccc3Cl)c2c1KRJKJUWAZOWXNV-UHFFFAOYSA-NEffect Profile
CuratedStrong anxiolysis and euphoria with moderate cognitive impairment, mild sedation
Tolerance & Pharmacokinetics
drugs.wikiNo tolerance chart. Our decay curves for these drugs were estimates, and a curve can make tolerance look longer-lasting than it is, which is the dangerous direction.
How fast tolerance to these drugs fades after a break has not been measured well enough to draw, so don't count on a dose you used to take still being safe: after time off, start with a much smaller amount and don't use alone. Mixing sedatives with each other, with alcohol or with opioids sharply raises the risk of a fatal overdose. If you've been using regularly, don't stop suddenly: withdrawal from benzodiazepines, alcohol or GHB/GBL can cause seizures or delirium, so get medical help to cut down gradually.
Sources: FRANK: benzodiazepines · Alcohol and Drug Foundation: GHB · FDA 2020: benzodiazepine boxed warning · FDA 2019: gabapentinoids and breathing · NHS: alcohol use disorder
Cross-Tolerances
Harm Reduction
drugs.wikiThis compound is a potent benzodiazepine; many users report significant effects at sub‑milligram doses, making volumetric dosing in ethanol or propylene glycol the safest practical method to avoid mismeasurement. TripSit’s benzo harm-reduction guidance specifically recommends liquid measurement for RC benzos active under 10 mg. It has a 3‑hydroxy group; by analogy to lorazepam/temazepam/oxazepam, most 3‑hydroxy benzodiazepines are cleared mainly by glucuronidation rather than CYP oxidation, so major CYP interactions may be fewer—this is a structural inference and not yet well-characterized for this exact drug. Strong additive CNS depression occurs with alcohol, opioids, GHB/GBL, barbiturates, tramadol, gabapentinoids, Z‑drugs, and sedating antihistamines; such combinations drive blackout, aspiration, and respiratory depression risks. Combining benzodiazepines with ketamine and other dissociatives increases ataxia and loss‑of‑consciousness risk; if someone becomes unresponsive, place them in the recovery position and seek help. Next‑day psychomotor and cognitive impairment can persist despite feeling ‘sober’; avoid driving or hazardous tasks until at least the following day. Amnesia and ‘delusions of sobriety’ are common across benzos and are frequently reported with 3‑hydroxyphenazepam; pre‑plan doses, avoid redosing for at least 2 hours after onset, and have a sober sitter to limit harm. Tolerance builds quickly with repeated use, and benzodiazepine withdrawal can be severe or life‑threatening; do not escalate doses to chase effects, and never stop chronic use abruptly—medical supervision is recommended for cessation. Novel/RC benzodiazepines are often found in counterfeit tablets with unpredictable potency; use only lab‑checked products where possible and treat any pressed ‘benzo’ of unknown origin as potentially over‑ or under‑dosed. User reports note easy dissolution in propylene glycol for accurate volumetric dosing. While insufflation has been reported anecdotally, non‑oral routes can increase unpredictability and harm; oral solutions offer more controllable kinetics.
References
Cited references
- PubChem: 3-Hydroxyphenazepam (chemical identity, synonyms)
- TripSit Wiki: Drug combinations (benzodiazepines interactions with alcohol, opioids, GHB/GBL, tramadol, ketamine)
- TripSit Wiki: Benzodiazepines (general risks; RC benzos usually active under 10 mg; volumetric dosing in ethanol/PG recommended)
- Isomer Design: 3-Hydroxyphenazepam (structure; identifiers)
- Bluelight: 3-Hydroxyphenazepam experiences (reports; dissolution in PG; sub‑mg cautions)
- Bluelight: Novel benzodiazepine, 3-Hydroxyphenazepam (user dosing cautions; next‑day effects)
- Drugs-Forum: Phenazepam (notes that 3-hydroxyphenazepam is a phenazepam metabolite)
- Bluelight: Dangerous Drug Combos (benzodiazepines with other CNS depressants; methadone note)